Veterinary Medicines

Valbazen 1,9 % 19 g/l Suspensie voor oraal gebruik

Not authorised
  • Albendazole
Download as PDF

Product identification

Medicine name:
Valbazen 1,9 % 19 g/l Suspensie voor oraal gebruik
Valbazen 1,9 % 19 g/l Suspension buvable
Valbazen 1,9 % 19 g/l Suspension zum Einnehmen
Active substance:
  • Albendazole
Target species:
  • Sheep
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Albendazole
    19.00
    gram(s)
    /
    1.00
    litre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Sheep
      • Milk
        4
        day
      • Meat and offal
        5
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC11
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Belgium
Package description:
  • Valbazen 1,9 % 5 l Container Oral suspension
  • Valbazen 1,9 % 2.5 l Container Oral suspension
  • Valbazen 1,9 % 0.5 l Container Oral suspension
  • Valbazen 1,9 % 0.25 l Container Oral suspension
  • Valbazen 1,9 % 1 l Container Oral suspension

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Purna Pharmaceuticals
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V134915
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 4/07/2022
Download
French (PDF)
Published on: 4/07/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 4/07/2022
Download
French (PDF)
Published on: 4/07/2022
Download
German (PDF)
Published on: 4/07/2022
Download